Technetium-99m methoxy-isobutyl-isonitrile (MIBI) has been recently introduced to trace regional myocardial perfusion; the first-pass and the equilibrium-gated images have been also used to assess myocardial function. In the present study, a quantitative index of regional myocardial wall motion obtained from perfusion electrocardiogram-gated images is proposed. The assumption of the study is based on the partial volume effect, i.e. changes in radioactivity counts correlated with variations in the object size. On this basis, changes in the detected radioactivity reflect changes in myocardial wall thickness during the cardiac cycle. Twenty patients with coronary artery disease and regional wall motion abnormalities and 10 normal subjects were studied by MIBI scintigraphy and contrast ventriculography; regional wall motion was analyzed by a radial method applied to both techniques. In each patient, absolute systolic changes in radioactivity and its ratio to normal reference values were determined in 9 anatomical cardiac regions according to the formula: (end-systolic counting profile - end-diastolic counting profile/end-diastolic counting profile) X 100. These values were compared with the quantitative wall motion of corresponding segments obtained from contrast ventriculography. The overall agreement between radioisotopic and ventriculographic techniques was 88% (158 of 180 segments). The intra- and interobserver variations in the measurements of the scintigraphic wall thickening index were ± 5.4 and ± 4.1 %, respectively. Normal, hypokinetic and akinetic ventriculographic segments showed wall thickening index values of 1.1 ± 0.19, 0.82 ± 0.2 and 0.45 ± 0.3, respectively(p < 0.001). Thus, the count-based wall thickening index, reflecting systo-diastolic transmurai radioactivity changes, provides an alternative means for the complementary evaluation of regional myocardial wall motion during perfusion studies with MIBI.

Keywords:
Myocardial scintigraphy, Isonitrile, Contrast ventriculography, Systolic thickening, Regional ventricular function
This content is only available via PDF.
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.